Ruth Arnon
Directeur/Bestuurslid bij MATRICELF LTD
Profiel
Roth Arnon is currently an Independent Director at Matricelf Ltd., a Member at the European Molecular Biology Organization, and a Member at the Israel Academy of Sciences & Humanities.
Previously, she served as an Independent Director at Compugen Ltd.
from 2007 to 2018.
She also held positions as a Director at Solegreen Ltd., a Director at HBL- Hadasit Bio-Holdings Ltd., and an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2007 to 2021.
Additionally, she served as a Trustee at the Albert B.
Sabin Vaccine Institute, Inc., a Vice President at the Weizmann Institute of Science from 1988 to 1997, and held positions at the International Vaccine Institute, the International Union of Immunological Societies, and the European Federation of Immunological Societies.
Dr. Arnon obtained a doctorate degree from Tel-Aviv University and Ben-Gurion University of the Negev, and graduate and doctorate degrees from The Hebrew University of Jerusalem.
Actieve functies van Ruth Arnon
Bedrijven | Functie | Begin |
---|---|---|
MATRICELF LTD | Directeur/Bestuurslid | 30-06-2021 |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | President | 19-10-2012 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Eerdere bekende functies van Ruth Arnon
Bedrijven | Functie | Einde |
---|---|---|
NOTABLE LABS, LTD. | Directeur/Bestuurslid | 06-07-2021 |
COMPUGEN LTD. | Directeur/Bestuurslid | 06-08-2018 |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Directeur/Bestuurslid | - |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Directeur/Bestuurslid | - |
European Federation of Immunological Societies | President | - |
Opleiding van Ruth Arnon
Tel-Aviv University | Doctorate Degree |
The Hebrew University of Jerusalem | Graduate Degree |
Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
COMPUGEN LTD. | Health Technology |
SOLEGREEN | Utilities |
HBL - HADASIT BIO-HOLDINGS LTD | Finance |
MATRICELF LTD | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
European Molecular Biology Organization | |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Commercial Services |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Commercial Services |
International Union of Immunological Societies | |
European Federation of Immunological Societies |